STING1 and cancer: Emerging evidence indicates that the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) axis is a major innate immune pathway involved in generating spontaneous antitumor T cell responses [8,9] and thus a promising cancer immunotherapy target [10].